![Susan Coles](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Susan Coles
Direttore/Membro del Consiglio presso
TME PHARMA N.V.
Profilo
Susan Coles is currently a Member at the New York State Bar Association and the Ontario Bar Association.
Since 2021, Ms. Coles has been an Independent Member of the Supervisory Board at TME Pharma NV.
Starting in 2026, Ms. Coles will be the Chief Legal Officer at Inventiva SA. Former roles include General Counsel at Stallergenes SAS from 2014 to 2017, Senior Counsel at Laboratoires Fournier SAS from 2002 to 2012, Senior Counsel at Abbott Products GmbH from 2002 to 2012, Senior Counsel at Mylan Laboratories SAS, General Counsel at Inventiva SA from 2019 to 2021, and General Counsel & Head-Finance at Vivet Therapeutics SAS. Education includes undergraduate studies at the University of British Columbia and graduate studies at the University of Toronto.
Posizioni attive di Susan Coles
| Società | Posizione | Inizio |
|---|---|---|
| TME PHARMA N.V. | Direttore/Membro del Consiglio | 24/06/2021 |
| INVENTIVA | Consigliere Generale | 22/04/2026 |
Ontario Bar Association
 Ontario Bar Association Miscellaneous Commercial ServicesCommercial Services Operates as association that provides legal services | Corporate Officer/Principal | - |
New York State Bar Association
 New York State Bar Association Miscellaneous Commercial ServicesCommercial Services Operates as a bar association | Corporate Officer/Principal | - |
Precedenti posizioni note di Susan Coles
| Società | Posizione | Fine |
|---|---|---|
| INVENTIVA | Consigliere Generale | 01/07/2021 |
| STALLERGENES | Consigliere Generale | 01/01/2017 |
Laboratoires Fournier SAS
 Laboratoires Fournier SAS Pharmaceuticals: MajorHealth Technology Manufactures pharmaceutical preparations | Consigliere Generale | 01/01/2012 |
Abbott Products GmbH | Corporate Officer/Principal | 01/01/2012 |
Mylan Laboratories SAS
 Mylan Laboratories SAS Pharmaceuticals: MajorHealth Technology Engages in pharmaceutical preparation manufacturing | Consigliere Generale | - |
Formazione di Susan Coles
Esperienze
Posizioni ricoperte
Attive
Inattive
Società nel listino
Aziende private
Relazioni
78
Relazioni di 1° grado
11
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
| Aziende private | 11 |
|---|---|
Stallergenes SA
 Stallergenes SA Pharmaceuticals: MajorHealth Technology Manufactures pharmaceutical products used for the treatment of allergy-related respiratory diseases | Health Technology |
Laboratoires Fournier SAS
Laboratoires Fournier SAS Pharmaceuticals: MajorHealth Technology Manufactures pharmaceutical preparations | Health Technology |
University of British Columbia
 University of British Columbia Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
University of Toronto
 University of Toronto Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
New York State Bar Association
New York State Bar Association Miscellaneous Commercial ServicesCommercial Services Operates as a bar association | Commercial Services |
Ontario Bar Association
Ontario Bar Association Miscellaneous Commercial ServicesCommercial Services Operates as association that provides legal services | Commercial Services |
Abbott Products GmbH | |
TME Pharma NV
 TME Pharma NV BiotechnologyHealth Technology Operates as clinical-stage biopharmaceutical company | Health Technology |
Mylan Laboratories SAS
Mylan Laboratories SAS Pharmaceuticals: MajorHealth Technology Engages in pharmaceutical preparation manufacturing | Health Technology |
Inventiva SA
 Inventiva SA BiotechnologyHealth Technology Operates as a clinical-stage biopharmaceutical company that develops oral small molecule therapies for the treatment of MASH and other diseases | Health Technology |
Vivet Therapeutics SAS
 Vivet Therapeutics SAS BiotechnologyHealth Technology Operates as a clinical-stage emerging biotechnology company that develops novel gene therapy treatments for rare and inherited metabolic diseases | Health Technology |
